Aurobindo Pharma reported INR52.01B in Operating Expenses for its third fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Operating Expenses Change
Cipla CIPLA:IN INR 46.75B 1.51B
Dr.Reddys Laboratories DRRD:IN INR 51.75B 4.33B
Hindustan Unilever HUVR:IN INR 122.99B 2.99B
Sun Pharmaceuticals SUNP:IN INR 88.94B 5.3B
UPL UPLL:IN INR 112.89B 8.99B